CJC-1295 No DAC is an experimental peptide used for research in peptide chemistry, molecular biology and Growth Hormone Releasing Hormone (GHRH) research. CJC-1295 No DAC peptide research helps to elucidate aspects of peptide structure, peptide-receptor interaction and signaling pathways.
Certificate of Analysis
Batch PA-0085 — 10mg
View COA
Research Grade Quality
Independently Tested
CJC-1295 No DAC
$89.99
Size / Strength
HPLC Verified
COA Included
Fast Dispatch
Discreet Shipping
100% Quality Guarantee
Every batch of CJC-1295 No DAC is independently third-party tested. 30-day money-back guarantee — no questions asked.
CJC-1295 No DAC – Research Overview
CJC-1295 No DAC is an experimental peptide analogue from GHRH research. Peptide experiments include elucidation of molecular characteristics, peptide-receptor interaction and signaling pathways, and do not include any medical uses of peptides.
Experimental research peptides like CJC-1295 No DAC offer scientists a means of working with well-defined molecular models of biological phenomena.
Peptides Australia offers CJC-1295 No DAC 10mg only as Research Use Only (RUO) laboratory reagent for scientific, analytical and educational research. Peptides Australia provides quality documentation with each lot of peptides, including analytical data and lot specific Certificates of Analysis (COA).
Research Highlights
- Independent Laboratory Tested
- Batch-Specific Certificate of Analysis
- Australia-Wide Dispatch
- Research Use Only
- HPLC Tested Peptide Material
What is CJC-1295 No DAC?
CJC-1295 No DAC is an artificially made peptide that is part of research work in the areas of peptide biology and GHRH research.
It is an analogue peptide that is derived from growth hormone-releasing hormone-related peptide sequence. CJC-1295 No DAC is used in research in order to get insights into the following areas:
- Structure of the peptide molecule
- Characteristics of receptor binding
- Signalling pathways of cells
- Mechanisms of biological communication
No DAC indicates that the research involves CJC-1295 that does not contain Drug Affinity Complex, which is present in another CJC-1295 research.
Scientific Background of CJC-1295 Research
Peptide research is an important field in biotechnology, molecular biology, and analytical chemistry.
Scientists study peptides due to the fact that their amino acid sequence influences:
- Molecular structure
- Chemical properties
- Stability properties
- Interactions with biological system
Artificial models of peptides allow scientists to study certain molecular properties in laboratory conditions.
CJC-1295 No DAC is a peptide research model that helps scientists to study GHRH-related molecular pathways.
Growth Hormone-Releasing Hormone (GHRH) Research Background
Growth hormone-releasing hormone (GHRH) is a natural signal molecule which is widely studied in molecular biology.
Scientists study GHRH-related molecular pathways in order to study:
- Peptide-receptor interactions
- Cellular signaling systems
- Mechanisms of hormonal communication
- Molecular regulation pathways
CJC-1295 No DAC is a studied model of a synthetic peptide analogue in this broader field of scientific research.
Peptide Classification
CJC-1295 No DAC is classified as a synthetic peptide analogue.
Peptides are small amino acid chains which are linked through peptide bond.
Properties of peptides depend on:
- Amino acid sequence
- Molecular structure
- Chemical modification
- Conditions of environment
Such properties are studied by scientists using laboratory methods such as chromatography and mass-spectrometry.
Molecular Characteristics of CJC-1295 No DAC
Understanding molecular characteristics is an essential part of peptide research.
CJC-1295 No DAC has a defined amino acid sequence that researchers evaluate through analytical methods.
Product Specification Table
Peptide Structure and Composition
CJC-1295 No DAC contains a modified peptide structure related to GHRH studies.
The main aspects studied through peptide structures include:
- Molecular structure
- Chemical features
- Analytical features
- Peptide properties
Structural analysis allows scientists to estimate how the peptide structure affects the characteristics of the laboratory.
Format of Lyophilised Powder
CJC-1295 No DAC comes in the form of a lyophilised powder intended for research.
Lyophilization represents a specific procedure of freezing and drying applied to peptide materials.
This method decreases the content of moisture and helps to ensure consistency during storage and transportation.
Advantages of lyophilized research peptides involve:
- Decreased moisture contact
- Storage consistency
- Laboratory documentation
- Handling consistency
Researchers should adhere to appropriate laboratory protocol regarding lyophilized peptide materials.
Stability Issues
Peptide stability might be affected by the environment.
Typically, researchers take into consideration:
- Temperature
- Moisture content
- Light
- Packaging
- Storage time
Proper storage environment helps to preserve the characteristics of research materials.
Researchers may access relevant educational information about:
- Peptide purity
- Peptide storage guide
- Certificate of analysis reading guide
CJC-1295 No DAC vs CJC-1295 with DAC
CJC-1295 No DAC and CJC-1295 with DAC are related peptide research compounds but have different molecular characteristics.
The main distinction is the presence or absence of the DAC modification.
| Feature | CJC-1295 No DAC | CJC-1295 with DAC |
|---|---|---|
| Research Category | GHRH analogue research | GHRH analogue research |
| DAC Modification | Not present | Present |
| Molecular Characteristics | Different peptide profile | Modified peptide profile |
| Research Interest | Peptide signalling studies | Peptide interaction studies |
| Classification | Research Use Only | Research Use Only |
Researchers studying these compounds evaluate their molecular properties, analytical characteristics, and research applications separately.
Why Researchers Study CJC-1295 No DAC
Scientific interest in CJC-1295 No DAC derives from its application as an experimental peptide model in molecular signalling research.
Laboratory studies are focused on elucidating:
- Peptide structure
- Receptor interactions
- Cellular communication pathways
- Molecular mechanisms
Such research adds to scientific understanding of peptides.
Peptide Receptor Interaction Research
Peptide receptor interaction research is conducted to understand how molecular structures interact in biological systems.
Laboratory research may be centered around:
- Binding properties
- Molecular relationship
- Structural interactions
- Signal transduction
CJC-1295 No DAC gives scientists a clear example of the peptide to study such molecular phenomena.
Growth Hormone Signalling Pathway Research
Growth hormone related signalling pathways represent a wide research field within molecular biology.
Researchers are interested in studying:
- Cellular communication
- Receptor activity
- Molecular regulation
- Biochemical processes
Research on CJC-1295 No DAC adds to scientific study of GHRH-related peptides.
Experimental Laboratory Models
CJC-1295 No DAC may be studied in controlled laboratory environments through:
- Analytical chemistry
- Molecular characterisation
- Peptide interactions
- Biochemical analysis
These studies are meant to enhance scientific understanding of peptide chemistry and molecular biology.
Manufacturing & Quality Requirements
The manufacture of reliable research peptides necessitates controlled processes of production, analytical testing, and documentation.
CJC-1295 No DAC 10mg is synthesised as a research peptide using peptide chemistry technology.
Peptide manufacturing for research purposes entails several procedures which include:
- Preparation of peptide sequence
- Synthesis
- Purification
- Analysis
- Lyophilisation
- Batch documentation
Such processes allow scientists to assess research peptides by providing quality information.
Solid Phase Peptide Synthesis (SPPS)
Solid Phase Peptide Synthesis (SPPS) is a conventional technique utilised in peptide chemistry and biotechnology for synthesis of synthetic peptides.
This technique allows the assembly of amino acids in a controlled manner to create a certain peptide sequence.
The general synthesis process includes:
- Selection of the peptide sequence
- Amino acid coupling
- Removal of the synthesis support materials
- Purification of the peptide
- Analysis
- Lyophilisation
- Batch documentation
It allows the production of research peptides with molecular characteristics.
Purification Process
After synthesis, purification is done to isolate the desired peptide from undesired by-products.
Purification facilitates:
- Incomplete peptide fragments
- Synthesis by-products
- Similar peptide molecules
- Impurities in the process
A well-regulated purification process allows for enhanced analytical uniformity and dependable research documentation.
Lyophilisation Procedure
After purification and analysis, CJC-1295 No DAC becomes lyophilized.
Lyophilisation is a process of freeze-drying commonly applied in lab peptide products.
The process ensures the reduction of water content while promoting consistency in storage and shipping.
Advantages of using lyophilized research peptides include:
- Minimization of exposure to water
- Increased storage consistency
- Increased laboratory convenience
- Documentation control
Appropriate laboratory procedures should be followed in handling lyophilized peptides.
Research Use Only (RUO)
CJC-1295 No DAC 10mg offered by Peptides Australia is available solely as Research Use Only (RUO) laboratory item.
The product is destined for:
- Scientific research
- Laboratory testing
- Educational study
- Controlled experiments
Use of CJC-1295 No DAC is not approved for therapeutic, diagnostic, veterinary or human purposes in Australia.
Research Materials vs Approved Medicines
Research peptides and approved medicinal products differ in their purpose.
Approved medicines pass through an evaluation process, which includes:
- Safety evaluation
- Clinical trials
- Production control
- Approval of medicinal uses
Research peptides are delivered for scientific study and are not similar to approved medicines.
Responsible Laboratory Research
Researchers and organizations using RUO items must make sure that all:
- Institutional requirements
- Laboratory safety rules
- Research standards
- Australian regulations
are observed when using CJC-1295 No DAC.
Why Choose Peptides Australia?
Research on peptides needs clear documentation, accurate information and reliable laboratory reagents. Peptides Australia offers the following for researchers through documentation suitable for:
- Universities
- Biotechnology firms
- Research labs
- Scientific institutions
Research Use Only
This product is intended solely for laboratory research purposes. Not for human consumption.
CJC-1295 No DAC – Storage & Handling
Storage & Laboratory Handling Requirements
Proper storage and handling are essential for the preservation of peptide research material.
CJC-1295 No DAC is provided as lyophilized powder, which should be stored according to proper laboratory procedures.
Temperature Requirements
Scientists should provide a proper storage environment to minimize the temperature fluctuations.
They include:
- Provision of proper storage conditions
- Minimizing temperature fluctuations
- Protection of materials during transportation
Moisture Requirements
Lyophilized peptides should be protected from excessive moisture.
It can include:
- Proper sealing of containers
- Minimizing humidity conditions
- Proper storage according to the manufacturer’s guidelines
Light Requirements
Scientists should provide the protection of peptide materials from the exposure to direct light. Proper storage conditions contribute to preserving the characteristics of the research material.
Laboratory Documentation
Facilities of the scientific nature usually keep records in respect of:
- Batches
- Conditions of storage
- Specifications of the product
- Experimental protocols
Documentation is essential in ensuring appropriate quality laboratory procedures.
Researchers are able to investigate:
- Guidelines for storing peptides
- How to interpret a Certificate of Analysis
- Laboratory Quality Control
CJC-1295 No DAC – Technical Specifications
Every batch of CJC-1295 No DAC is independently analysed before dispatch. The values below describe the current research batch.
| Product Name | CJC-1295 No DAC |
|---|---|
| CAS Number | 863288-34-0 |
| Molecular Formula | C₁₅₂H₂₅₂N₄₄O₄₂ |
| Molecular Weight | 3368.7 g/mol |
| Quantity / Strength | 10mg |
| Purity | ≥ 99% (HPLC) |
| Form | Lyophilised Powder |
| Appearance | White Lyophilised Powder |
| Batch Number | PA-0085 |
| Storage Conditions | 2°C-8°C (Refrigerated) |
| Category | Muscle Growth & Performance |
| Intended Use | Research Use Only — not for human consumption |
CJC-1295 No DAC – Certificate of Analysis
Every batch of CJC-1295 No DAC is independently tested before dispatch. View the full COA for the current batch below.
Certificate of Analysis (COA)
Batch Number PA-0085
≥ 99%
Purity
HPLC
Confirmed
Identity
Mass Spec
Pass
Heavy Metals
ICP-MS
| COA Information | Purpose |
|---|---|
| Product Name | Confirms peptide identification |
| Batch Number | Supports traceability |
| Purity Results | Provides analytical evaluation |
| Testing Method | Identifies laboratory techniques |
| Identity Testing | Supports molecular confirmation |
| Quality Review | Documents assessment |
Batch Traceability and Quality Documentation
Batch traceability is an essential aspect of responsible supply of research peptides.
Documentation for CJC-1295 No DAC may include:
- Product identification
- Batch number
- Analytical data
- Quality standards
- Storage conditions
Proper record keeping facilitates laboratories, universities, biotechnology companies, and other research institutions in recording their lab materials.
Purity Testing & Certificate of Analysis (COA)
Analytical testing offers researchers data about peptide identity, purity, and quality standards.
Prior to choosing peptides in a laboratory setting, researchers typically consider:
- Purity data
- Analytical testing data
- Peptide identity
- Batch documentation
High-Performance Liquid Chromatography (HPLC)
High-Performance Liquid Chromatography (HPLC) is among the most common analytical tools for assessing the purity of peptides.
HPLC separates different substances of the test sample and generates chromatographic data which is further used in analytical testing.
For CJC-1295 No DAC research peptides, HPLC analysis might provide information about:
- Purity rate
- Composition of the sample
- Related substances
- Batch consistency
HPLC testing is widely practiced in peptide chemistry, biotechnology, and academic research laboratories.
Those researchers who want to learn more about analytical testing techniques should consider:
Understanding Peptide Purity
HPLC vs. LC-MS Testing
Third-Party Laboratory Testing
LC-MS Identity Testing
Liquid Chromatography–Mass Spectrometry (LC-MS) is widely used for peptide identification purposes.
LC-MS analysis allows researchers to assess:
- Molecular weight
- Expected identity of the peptide
- Structural features
Combination of several analytical techniques allows obtaining additional information about research peptides.
Certificate of Analysis Explained
A Certificate of Analysis (COA) is a batch-specific quality document containing analytical information about a research peptide.
A typical COA may include:
COA helps scientists to analyse the specifications of the laboratory material prior to starting scientific experiments.
Scientists who plan to buy CJC-1295 No DAC in Australia should check the Certificate of Analysis, analysis and tests details, as well as quality guidelines of suppliers before choosing research peptides.
Certificate of Analysis per Batch
Per batch COAs provide information related to analysis of the product itself. It will help with:
- Laboratory documentation
- Material verification
- Research traceability
Analysis in an Independent Laboratory
Analytical testing gives information about:
- Peptide identification
- Purity characteristics
- Batch consistency
HPLC Tested Peptides
HPLC testing gives information about the purity and composition of the peptide. Researchers can check testing documentation while analyzing laboratory reagents.
Secure Packaging
The correct packaging can be used to protect the lyophilized research reagents during transportation and storage.
Australia Wide Dispatch
Dispatching is reliable and will assist:
- Research institutions
- Universities
- Biotechnology firms
- Scientific laboratories
Researchers wishing to purchase CJC-1295 No DAC in Australia need to consider specifications, Certificate of Analysis, analytical testing and Research Use Only status while selecting laboratory reagents.
Research Disclaimer
For Research Use Only — Not for Human Consumption
This content is provided for educational, scientific and research-information purposes only. It does not provide medical advice, treatment recommendations or personal dosage instructions. Available evidence concerning CJC-1295 (No DAC) includes preclinical research and ongoing or completed clinical investigations. Further research is required to better understand its safety, pharmacology and potential efficacy for specific research applications.
- Not for human or veterinary use
- No claims are made regarding safety or efficacy in humans
- Must be handled with appropriate laboratory safety equipment
- Purchaser assumes all responsibility for legal, compliant use
References
5 sources- 1Jetté L, Léger R, Thibaudeau K, et al. Human Growth Hormone-Releasing Factor (hGRF)1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog. Endocrinology. 2005;146(7):3052-3058.PubMed: https://pubmed.ncbi.nlm.nih.gov/15817669/
- 2Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults. Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799-805.PubMed: https://pubmed.ncbi.nlm.nih.gov/16352683/
- 3Ionescu M, Frohman LA. Pulsatile Secretion of Growth Hormone (GH) Persists During Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog. Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4792-4797.PubMed: https://pubmed.ncbi.nlm.nih.gov/17018654/
- 4Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YC, Felix AM. Rapid Enzymatic Degradation of Growth Hormone-Releasing Hormone by Plasma In Vitro and In Vivo to a Biologically Inactive Product Cleaved at the NH2 Terminus. Journal of Clinical Investigation. 1986;78(4):906-913.PubMed: https://pubmed.ncbi.nlm.nih.gov/3093533/
- 5Australian Government, Therapeutic Goods Administration (TGA). Concerns Regarding the Public Health Risks Associated with Unapproved Peptide Products. Therapeutic Goods Administration. 19 June 2026.TGA: https://www.tga.gov.au/news/media-releases/concerns-regarding-public-health-risks-associated-unapproved-peptide-products
Citations are provided for research reference and open in a new tab. Listing a study does not imply it evaluated this specific product.
CJC-1295 No DAC – Frequently Asked Questions
Researchers Also Purchase
Why Researchers Choose Us
Research-Grade Quality. Trusted by Researchers Across Australia.
Learn About Our QualityDiscreet Packaging
Fast Australia-Wide Delivery
Expert Support
30-Day Money Back